Prostate cancer is the most prevalent tumor in males and its incidence is expected to increase as the population ages. Prostate cancer is treatable by excision if detected at an early enough stage. The challenges of early diagnosis require the discovery of novel biomarkers and tools for prostate cancer management. Results: We developed a novel feature selection algorithm termed associative voting (AV) for identifying biomarker candidates in prostate cancer data measured via targeted metabolite profiling MS/MS analysis. We benchmarked our algorithm against two standard entropy-based and correlation-based feature selection methods (Information Gain and ReliefF) and observed that, on a variety of classification tasks in prostate cancer diagnosis, our algorithm identified subsets of biomarker candidates that are both smaller and show higher discriminatory power than the subsets identified by Information Gain and ReliefF. A literature study confirms that the highest-ranked biomarker candidates identified by AV have independently been identified as important factors in prostate cancer development. Availability: The algorithm can be downloaded from the following
INTRODUCTION

Clinical question
Prostate cancer is the most prevalent tumor in males in developed countries and a major cause of death due to malignancy. This problem will be aggravating with increasing life-time expectancy in the future since the frequency of prostate cancer is rampant in elderly men. A curative treatment of prostate cancer is possible, given that the tumor is diagnosed in an organ-confined stage * to whom correspondence should be addressed and completely removed. However, early diagnosis is hampered by the lack of symptoms and markers. Thus, novel diagnostic and prognostic tools for prostate cancer management are urgently needed (Dhanasekaran et al., 2001; Tomlins et al., 2006) .
One major challenge to reduce prostate cancer mortality demands the discovery of plasma prognostic markers allowing the distinction between indolent and aggressive tumors and the establishment of early detection, risk assessment and treatment programs. An international project, funded in the framework of the IMGuS (Institute for Medical Genome Research and Systems Biology, Vienna) research program, on prostate cancer pursues a systems biology approach analyzing genomic, proteomic and metabolomic components of samples from prostate cancer patients (Herwig et al., 2007) , and its consortium aims at the identification of a new set of such diagnostic and prognostic molecular signatures and markers, and attempts to reveal their inherent biological functions.
The metabolomic analysis comprises a set of quantitative targeted assays applied on serum samples from patients with aggressive (Gleason score (GS) 8-10) and non-aggressive (GS6) tumors and healthy age matched controls. Metabolite concentration profiling shows potential to discover multivariate biomarker sets that assist in early diagnosis, disease staging and subtyping at the molecular level, and will open up the opportunity to develop individually adapted forms of treatments in different cancers; especially, once metabolic changes can be characterized on a comprehensive scale (Baumgartner and Graber, 2008; Weinberger and Graber, 2005) .
Biochemical background
A metabolomic approach seems promising as tumor cells exhibit defined changes in their intermediary metabolism due to two distinct influences. First, the internal alterations, associated with transformation and immortalization, have profound effects on gene transcription patterns and, consequently, influence protein levels and enzyme activities, which lead to all sorts of abnormal metabolite concentrations. Second, cells in solid tumor tissues frequently encounter external limitations like ischemia and, thus, constrained availability of oxygen and various substrates for energy generation and synthetic processes. Therefore, these tissues show a characteristic, fermentation-like phenotype with elevated production of certain organic acids like pyruvate and lactate and an increased turn-over of amino acid catabolism (Boros et al., 2002) . Supplementary characteristics should be measured in specific cancers. For example, as far as prostate cancer is concerned most metabolic studies have focused on the role of androgens, such as testosterone, and their biosynthesis and degradation, while research is also directed to nutritional effects (Dagnelie et al., 2004) . Another aspect, where metabolomics could greatly enhance the understanding of the pathomechanisms in prostate cancer, is the huge area of intracellular signaling. Up to now, the characterization of signaling pathways is mainly focused on protein phosphorylation and kinase cascades although various metabolites, such as sphingolipids like ceramide, sphingosine and sphingosine-1-phosphate, are frequently acting as intracellular second messengers. Although all three sphingolipids are structurally similar, they regulate different signal transduction pathways with high specificity and are directly involved in the regulation of many cellular processes, in particular also in cell proliferation and apoptosis (Jaffrezou and Laurent, 2004 ).
Feature selection for biomarker discovery
A recent biomarker discovery strategy in human disease involves the search for novel diagnostic, prognostic and predictive markers in massive and complex data sets gathered from modern MS/MS profiling platforms (Baumgartner et al., 2004) . This process is highly data-driven and requires sophisticated data mining concepts for identifying, verifying and interpreting robust and generalizable biomarkers. Analytical and computational challenges are consequences of the properties of high dimensional data spaces, such as high variability, presence of strong correlations and confounding due to the multimodality of heterogeneous and dynamic processes in cancer biology that are inherent in experimental profiling data (Clarke et al., 2008) . Feature selection, perhaps the most widely used approach to the analysis of highdimensional data spaces before classification and biomedical interpretation, reduces the dimensionality of data significantly and searches for those feature subsets that show superior discriminatory and predictive performance. However, many popular approaches do not optimally reflect the characteristics of given MS/MS data structures, and thus the apparent need arises for alternative advanced data analysis strategies for identifying novel biomarker candidates in metabolomic data sets. Hence, we propose a novel feature selection method for the identification of biomarker candidates distinguishing patients with aggressive and non-aggressive stages of prostate cancer and healthy controls.
Filter-based feature selection
Our feature selection algorithm for identifying metabolic markers in prostate cancer is a filter approach, a particular sub-category of feature selection (Hall and Holmes, 2003) . Filter approaches use an evaluation criterion to assess the discriminatory power of the attributes. As a result, a ranked list is returned to the user. Popular methods like Information Gain (Quinlan, 1993) and ReliefF (Kononenko, 1994) apply entropy-and correlation-based evaluation criteria, respectively.
The information gain of an attribute reflects the amount of entropy of the class labels that can be explained by the attribute. Given an attribute ai, its information gain IG(ai) w.r.t. class cj is defined as the difference between the entropy of class cj and the conditional entropy of class cj given ai. The overall information gain of attribute ai is the sum over all information gains w.r.t. all class labels. Information gain is a univariate filter approach, because it evaluates each attribute separately.
ReliefF is the extension of Relief to noisy, incomplete, and multiclass data sets. The main idea of Relief is that the values of a significant attribute are correlated with the attribute values of an instance of the same class, and uncorrelated with the attribute values of an instance of the other class. For a given instance, Relief determines its two nearest neighbors: one from the same class, and one from the other class. Then it estimates the value of an attribute ai by the difference between the conditional probabilities P (different value of ai | nearest instance from different class) and P (different value of ai | nearest instance from same class). Note that the nearest instances are identified according to the sum of differences to all attributes, so that Relief as well as ReliefF are multivariate filter approaches.
In our algorithm we evaluate attributes by a rule-based evaluation criterion. More precisely we evaluate attributes by a special form of association rules. Most previous work on the use of association rules for feature selection has been done in the area of text mining. 
METHODS
Data collection
2.1.1 Blood serum sample collection and processing Serum samples were obtained from the Prostate Cancer Biobank in Innsbruck, Austria. The serum procurement, data management, and blood collection protocols were approved by the local Ethical Review Board. Blood samples from patients diagnosed with prostate cancer and from healthy controls, respectively, were obtained from the Prostate Cancer Screening program open to the general public in Tyrol (Bartsch et al., 2001) . After informed consent of the patients, blood samples were drawn by venous puncture using Sarstedt 9 ml z-gel serum monovettes, serum was obtained by centrifugation (4 min, 1800 g) and frozen in 2 ml cryovials (Simport) at −80
• C. At first use the sera were distributed into 250 µl aliquots to avoid repeated freeze-thaw cycles.
2.1.2 Patient and control cohorts 114 serum samples from control screeners and 206 serum samples obtained prior to treatment from prostate cancer patients who underwent radical prostatectomy after cancer diagnosis (121 GS6, 85 GS8-10) were studied. The inclusion criteria for prostate cancer patients required the histopathological assessment of radical prostatectomy specimens. Histopathological results were confirmed by a second independent pathologist from the State Hospital Klagenfurt in Austria. The age matched normal controls were defined by PSA measurements covering a time period of at least three years with no increase of PSA above 0.5 ng/ml. Clinical data of the patients were retrieved from the clinical databases and the patients' history records.
2.1.3 MS-analysis and data pre-processing Metabolite concentrations were detected in blood sera (100 l per sample) of the 320 patients by targeted MS/MS analysis (Weinberger and Graber, 2005) . In detail, sample aliquots were directly extracted in Folch solution (i.e. glyco-and phospholipids, and oxidized fatty acids) or derivatized (i.e. amino acids, biogenic amines, acylcarnitines, reducing mono-and oligosaccharides) with a liquidhandling-system, and analyzed either by FIA-MS/MS or LC-MS/MS combined with MRM, precursor and NL scans using a 4000 Q TRAP system equipped with an electrospray source. Isotope correction was performed on the mass profile of lipids (Eibl et al., 2008) . Concentrations were calculated from the raw MS spectra by reference to a wide range of appropriate internal standards (stable isotopes) and filtered based on their signal-to-noise threshold (> 4) and overall percentage of missing values (< 80%) across all cohorts.
Data set description
The filtered data set includes measurements of 319 individuals divided into three groups (one sample was rejected because of insufficient serum material). 85 of the individuals belong to the group with GS from 8 to 10. A total of 120 subjects belong to the group with a GS equal 6, and 114 individuals form the group of healthy controls. Each subject is described by 112 measured metabolites, referred to as attributes or features. Using this data set, we examine the four dichotomous problems of identifying biomarker candidates discriminating
• cancer (defined as GS6 and GS8-10) vs. control,
• GS6 vs. GS8-10,
• GS6 vs. control, and
• GS8-10 vs. control.
Computational Approach
Our feature selection algorithm for identifying metabolic markers in prostate cancer evaluates attributes by class association rules, a special form of association rules. A class association rule is an expression I ⇒ c, where I is a set of attribute-value pairs, called items, and c is a class label. A data object o, which is also a set of attribute-value pairs, matches an item i = (Aj; t) if and only if o has value t in attribute Aj. Furthermore, o matches an itemset I if and only if o matches every item i ∈ I. For continuous attributes, as in our case, the value ranges have to be discretized into intervals; we do this by the minimal description length method of Fayyad and Irani, 1993 . In a recursive fashion, this method uses the class information entropy of candidate partitions to select split-points that have high information gain. For each numerical feature a set of split-points is obtained which define the boundaries of the intervals of the nominal attribute values.
Class association rules arise from the integration of association rule mining and classification, known as associative classification (Liu et al., 1998) . Therefore, associative classification is divided into two major steps. As a first step, association rule mining algorithms, such as Apriori (Agrawal and Srikant, 1994) or FPgrowth (Han et al., 2000) , are used to generate the complete set of association rules satisfying certain support and confidence constraints.
Using class(o) to denote the class of data object o, we define the support of a rule I ⇒ c in a data set T as
the percentage of data objects in T matching itemset I and having class label c. The confidence of a rule I ⇒ c in a data set T is defined as
the percentage of all data objects matching itemset I that have class label c.
For classification, the second step of associative classification, all class association rules are sorted according to support, confidence and the size of the rule's itemset. The first rule, matching a given test object is used for prediction. If there is no rule that applies the majority class (default class) is taken. Also, other approaches, such as a majority voting (Yin and Han, 2003) or a combined effect (Li et al., 2001 ) on the best rules matching a test object are possible.
In our approach, we adapt the concept of associative classification to feature ranking by using the determined class voting for evaluating the participating class association rules instead of using it for prediction. First, we generate the set of all class association rules R = {I ⇒ c} by a modified version of the Apriori algorithm. For this rule set we determine the class-conditional distribution of the confidence values P (conf(R; T )|c) to normalize the class voting in a later step. Then, we process all test objects as follows: As in associative classification we determine the applicable rules for each test object. A rule I ⇒ c is applicable to a data object o if and only if I ∈ o, i.e. o matches I. Since Chen et al., 2006 has shown that a majority voting is more accurate than a decision on a single rule, but as too many rules result also in worse prediction accuracy, we use the (at most) three best applicable rules of each class to calculate a voting. In associative classification this voting is used to decide, which class is predicted. Our adaptation is to use this voting to evaluate the applicable rules; we do this by keeping a running score for each rule that is initialized by zero.
The voting used in our approach is composed as follows: First, for each test object, we determine the mean confidence conf(Bc; T ) of the (at most) three best applicable rules Bc per class c. We use the mean value to account for the possibility that different numbers of applicable rules per class occur. Then, we normalize the calculated mean values by the mean confidence conf(Rc; T ) of all rules Rc of the corresponding class c to account for differences in the distribution of confidence among the classes. Formally, we calculate the voting vc for each class c by the following formula:
The class c with highest value vc is the "winner" of the voting. We increase by one the scores for all rules that predict the winning class, and decrease by one the scores for all rules in the voting that predict the other class.
This increase and decrease of the scores of the rules are summarized. The scores of the rules are assigned to the items part of the itemsets predicting the class of the rule by increasing the score of an item by the score of each rule in which it appears. To get the final estimate of the quality of an attribute, we summarize the scores of the items, which are the bins where the attributes are discretized during the run of the algorithm. Finally, the aggregated score of each attribute is used to rank them.
RESULTS
To evaluate our algorithm, termed Associative Voting (AV), we conducted a 10-fold cross-validation procedure and compared our results to those of Information Gain (IG) and ReliefF (RF). For IG and RF, we used the implementation of the Weka data mining software (Witten and Frank, 2005) . To provide a unified framework for our experiments, we also implemented AV based on classes of Weka.
We considered an accumulated score to ensure the comparability of all three methods, which have different ranges of scores. First, we discarded all low ranked attributes up to five percent of the accumulated score, leaving only high-quality attributes according to the individual methods' scoring schemes. Taking the quality of an attribute into account, and not only its rank, is especially important in rankings with many low scoring attributes. To demonstrate this, we consider the following example of attribute scores: In this example, the five lowest ranking attributes are discarded because the five top ranked attributes already account for 95% of the accumulated score. We then selected the attributes constituting the best 25%, the best 50%, the best 75%, and 100% of the remaining 95% of the accumulated score. We applied a logistic regression model on these attribute sets to evaluate the discriminatory power using the area under the ROC curve (AUC) for comparison. Figure 1 shows the number of attributes and the AUC values of the selected subsets for the comparison cancer vs. control. It can be seen that AV generates smaller subsets of k% best ranked attributes than IG and RF and achieves higher AUC values for three of the four subsets.
A summary of comparisons for cancer vs. control, GS6 vs. GS8-10, GS6 vs. control, and GS8-10 vs. control is given in Table  1 . AV outperforms IG and RF in nine of the 16 comparisons. Additionally, we achieve in one comparison an equal AUC value with less attributes. For the remaining subsets the AUC values are in a similar range of IG or RF. Figure 2 (a) lists the 10 top ranked metabolites of AV distinguishing cancer vs. control. The metabolites PC a C16:0 and PC a C18:0, both lysophosphatidylcholine (LPC) with saturated fatty acid chains, have particularly high scores. Also Serotonin, a monoamine neurotransmitter, the proteinogenic amino acid Aspartic Acid (Asp) and the non-proteinogenic amino acid Ornithine are highly ranked.
The comparison of GS6 vs. GS8-10 did not reveal any reliable marker candidates. As depicted in Figure 2 (b) , the scores of the top ranked attributes for GS6 vs. GS8-10 are much lower than those for cancer vs. control. Additionally, the standard deviations are very high, indicating instabilities among the splits of the 10-fold crossvalidation. Figure 3 shows the 10 top ranked metabolites of IG and RF. Similar to AV, IG also ranks the two LPCs and Ornithine high. The ranking produced by RF is less similar to that of AV but Serotonin is also among the 10 best ranked metabolites. Additionally, Asp is highly ranked by IG as well as RF. In summary, the ranking of IG is more similar to the ranking of AV than the ranking of RF.
DISCUSSION
We developed a new powerful feature selection algorithm, AV, and compare its discriminatory performance to two popular methods, IG and RF. IG evaluates each metabolite according to its correlation with the class labels. Therefore, the selected biomarker candidates are highly likely to be correlated with each other, leading to a lower discriminatory power of attribute sets. In contrast, AV applies a multivariate criterion. The support and confidence of a class association rule contains information about the discriminatory power of the combination of the attribute-value pairs. By the ordering of the rules according to these characteristics, AV identifies biomarker candidates that complement one another, rather than sets of redundant (correlated) features. RF judges the merit of a metabolite by the correlation of the attribute value with the attribute values of the k nearest neighbors. Both RF and AV are multivariate feature selection strategies, but they are inherently different in the manner in which they incorporate relations to other attributes: RF incorporates other attributes in the identification of the k nearest neighbors; in contrast, AV incorporates other features by their co-occurrence in rules.
We observed that the ranking of AV is more similar to the ranking of IG and less similar to the ranking of RF. The similarity with IG is due to the fact that support and confidence are correlated with the concept of entropy. This means that high support and confidence values correspond to high entropy of the attributes. The difference is that AV evaluates combinations of attributes, not single attributes, which leads to the variations in the rankings. The evaluation criterion of RF is less related to the entropy of the attributes and therefore the ranking of RF is quite different from those of IG and AV. Moreover, the evaluation criterion of RF is not strict enough. The differences between the scores are very small, leading to a significantly higher number of biomarker candidates for the best 75% and 100% attribute subsets.
To make the three feature selection methods better comparable, we introduced an accumulated score. Commonly, sets of k best ranked attributes are compared without taking into account the different scales of scores. The score of an attribute reflects how well suited this attribute is deemed by an evaluation criterion. Discarding the score, while keeping only the rank, ignores this important quality measure. For example, let us assume that the scores of the three top ranked attributes of IG and RF lie in the range of 0.7 to 1. Using the common approach for comparison, the three best ranked attributes of IG are considered to be as important as the three best ranked attributes of RF. Because the score of IG ranges from 0 to 1 and that of RF from −1 to 1, scores in the range of 0.7 to 1 have higher merit on the IG scale than on the RF scale. Thus, different qualities are compared. By using the k% best attributes according to the accumulated score (leaving the ranking of the attributes unchanged) the range of the scores, and therefore the quality of the selected attributes, are considered. Thus, we achieve a better comparability of the methods.
We used a logistic regression model to determine the discriminatory power of the attribute sets. Our motivation for selecting this model is twofold: First, logistic regression is a well established standard in biomedical data analysis. Second, a logistic regression model does not require searching for optimal parameter settings. As a result, the obtained classification performances are easily comparable because they do not depend on particular parameter settings. Next we deliberated the biological plausibility and substantiation of the identified marker sets. In this respect, primarily metabolites were studied that were consistently within the 10 best performers for the three comparisons cancer versus control, GS6 versus control and GS8-10 versus control (the fourth comparison GS6 versus GS8-10 did not reveal any reliable markers). This list includes the two saturated lysophosphatidylcholines (LPC) with chain length 18 and 16, and the amino acids Serotonin, Asp and Orn. A Wilcoxon rank sum test consistently indicates that the two LPCs, Orn and Serotonin have significantly lower concentrations in the cancer groups (p < 0.001 for all four metabolites), whereas Asp show significantly lower levels (p < 0.001) in the controls.
In general, lysophospholipids can bind to and activate specific cell-surface G protein-coupled receptors (GPCRs) that initiate cell growth, proliferation, and survival pathways, and show altered concentrations in cancer cells, and thus in combination with other specific markers have the potential to contribute to early diagnosis (Murph et al., 2007) . In this context, significantly decreased levels of several LPCs were reported in plasma of colorectal cancer patients compared to controls .
Ornithine decarboxylase (ODC) is the key enzyme in the polyamine synthesis pathway and is overexpressed in a variety of cancers. ODC depletes Orn by catalyzing the decarboxylation of Orn and producing, as a result, diamine putrescine. Previous studies concluded that ODC is overexpressed in both benign prostatic hyperplasia and neoplastic tissues and that ornithine decarboxylase overexpression appears to be an early event in prostate carcinogenesis. Interestingly, ODC overexpression was also detected in patients who underwent androgen ablation therapy, suggesting ODC overexpression may contribute to the androgenindependent survival of prostate cancer cells (Young et al., 2006) .
Clinical data from 13 studies demonstrated a cancer-related free amino acids (FAA) profile in plasma. An abnormal FAA profile might be presented via the total reflection of cancer-induced protein metabolism in tumors, skeletal muscle and the liver in cancer patients. In this context, redistribution or translocation of plasma FAAs to support visceral or tumor protein synthesis is an essential feature (Lai et al., 2005) . For instance, prostate epithelial cells accumulate a high level of Asp that is utilized as a substrate for their unique function of production and secretion of enormously high levels of citrate. In most mammalian cells Asp is synthesized; and, therefore is a nonessential amino acid. In contrast, in citrate-producing prostate cells, Asp is an essential amino acid that must be derived from circulation. Therefore, these cells must possess a plasma membrane-associated Asp uptake transport process to achieve their functional activity (Franklin et al., 2006) . The increased levels of Asp in plasma of cancer patients might relate to the metabolic transformation that characterizes the essential transition of normal citrate producing epithelial cells to malignant citrate-oxidizing cells. Additionally, increased protein biosynthesis was described in localized prostate cancer, where the breakdown of the resulting proteins leads to increased accumulation of elemental nitrogen, which will have to be eliminated through nitrogen breakdown and urea cycle pathways. In this context, significantly increased levels of Asp in the prostate cancer specimens were reported (Taylor et al., 2007) .
Recently the role of Serotonin in prostate cancer proliferation has been discussed in the literature. The results of Siddiqui et al., 2006 imply a significant effect of both growth inhibition and induction of apoptosis by Serotonin in prostate cancer cell lines. Also Dizeyi et al., 2004 confirm the important role of Serotonin in tumor progression.
CONCLUSION
In this paper we presented a new feature selection method for the identification of biomarker candidates in complex metabolic data sets and applied this method to the problem of distinguishing patients with aggressive and non-aggressive prostate cancer and healthy controls. Associative voting (AV) adapts the concept of associative classification by using the determined class voting for evaluating the class association rule participating in building the voting instead of using it for prediction. We evaluated our algorithm by a 10-fold cross-validation procedure. The predictive power of the identified metabolic markers was evaluated using ROC analysis and compared to those of IG and RF. Our experiments showed that AV selects fewer biomarker candidates than IG, and RF selects far more biomarker candidates than AV and IG. The biomarker sets, selected based on the ranking of AV had a higher discriminatory power than those determined based on the rankings by IG and RF.
Finally, we were able to verify and interpret the identified biomarkers by literature. Using statistical significance testing we observed that metabolites within the selected biomarkers sets have significantly different concentrations in the cancer groups compared to the controls. In this ongoing research, we intent to investigate the applicability of our feature ranking method on further data sets. Moreover, we attempt to verify the identified biomarker sets on a blinded external cohort.
In summary, associative voting is a powerful data mining tool for identifying metabolic marker candidates in cancer.
